Perfuse Therapeutics

0 followers


Perfuse Therapeutics is a seed-stage company pursuing a novel mechanism to improve retinal perfusion in the context of various retinal diseases starting with glaucoma

Industries

Employees

1-10

Links


Org chart

Andrew Melie
Analytical Scientist
Christopher Romeo
Principal Scientist, Device And Formulation
Heather Schmitt
Clinical Development Scientist
Maria Zaretskaia, M.D.
Principal Scientist
Karen Brennan
Vice President, Pharmaceutical Development
Phillip Lai
Chief Medical Officer
Angela Glendenning
Vice President Of Product Development

Teams

This company has no teams yet